Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

被引：0

作者：

Grupp, Stephan A. ^{[1
]}

Maude, Shannon L. ^{[1
]}

Rives, Susana ^{[2
]}

Baruchel, Andre ^{[3
]}

Boyer, Michael ^{[4
]}

Bittencourt, Henrique ^{[5
]}

Bader, Peter ^{[6
]}

Buchner, Jochen ^{[7
]}

Laetsch, Theodore W. ^{[8
,9
]}

Stefanski, Heather ^{[10
]}

Myers, Gary Douglas ^{[11
]}

Qayed, Muna ^{[12
]}

Pulsipher, Michael A. ^{[13
]}

De Moerloose, Barbara ^{[14
]}

Yanik, Gregory A. ^{[15
]}

Davis, Kara L. ^{[16
]}

Martin, Paul L. ^{[17
]}

Nemecek, Eneida R. ^{[18
]}

Peters, Christina ^{[19
]}

Krueger, Joerg ^{[20
]}

Balduzzi, Adriana, Sr. ^{[21
,22
]}

Boissel, Nicolas ^{[23
]}

Mechinaud, Francoise ^{[24
]}

Leung, Mimi ^{[25
]}

Eldjerou, Lamis ^{[25
]}

Bleickardt, Eric ^{[25
]}

Mueller, Karen Thudium ^{[26
]}

Hiramatsu, Hidefumi ^{[27
]}

机构：

[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[2] Hosp St Joan de Deu Barcelona, Dept Hematol & Oncol, Barcelona, Spain

[3] Hop St Louis, Dept Pediat, Paris, France

[4] Univ Utah, Blood & Marrow Transplant Program, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Salt Lake City, UT USA

[5] Hosp Clin, Belo Horizonte, MG, Brazil

[6] Klin Kinder & Jugendmed, Stem Cell Transplantat & Immunol, Frankfurt, Germany

[7] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway

[8] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[9] Childrens Hlth, Pauline Allen Gill Ctr Canc & Blood Disorders, Dallas, TX USA

[10] Univ Minnesota, Pediat Blood & Marrow Transplantat, Minneapolis, MN USA

[11] Childrens Mercy Hosp, Kansas City, MO 64108 USA

[12] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA

[13] Childrens Hosp Los Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA

[14] Ghent Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplantat, Ghent, Belgium

[15] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA

[16] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA

[17] Duke Univ, Med Ctr, Pediat Blood & Marrow Transplantat, Durham, NC USA

[18] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[19] St Anna Childrens Hosp, Stem Cell Transplantat Unit, Vienna, Austria

[20] Hosp Sick Children, Div Hematol Oncol BMT, Toronto, ON, Canada

[21] San Gerardo Hosp, HSCT Pediat Unit, Monza, Italy

[22] San Gerardo Hosp, Lab Cell Therapy S Verri, Monza, Italy

[23] Hop St Louis Univ, Paris, France

[24] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia

[25] Novartis Pharmaceut, E Hanover, NJ USA

[26] Novartis Inst BioMed Res, E Hanover, NJ USA

[27] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

170

引用

页数：2

共 50 条

[41] Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
Hao, Yanni
Eldjerou, Lamis K.
Yang, Hongbo
Qi, Cynthia
Globe, Denise
BLOOD, 2017, 130
[42] Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia
Eldjerou, Lamis K.
Acker, Christopher
Howick, Damien
Clough, Lee
Fuchs, Miriam
Salmon, Florence
Willert, Jennifer
Tiwari, Ranjan
Pujols, Mayo
Robson, Matthew
BLOOD, 2019, 134
[43] Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic Leukemia
Fong, David
Tiwari, Ranjan
Acker, Christopher
Clough, Lee
Willert, Jennifer
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 579.e1 - 579.e10
[44] Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis
Buechner, Jochen
Grupp, Stephan A.
Maude, Shannon L.
Boyer, Michael
Bittencourt, Henrique
Laetsch, Theodore W.
Bader, Peter
Verneris, Michael R.
Stefanski, Heather
Myers, Gary Douglas
Qayed, Muna
Pulsipher, Michael A.
De Moerloose, Barbara
Hiramatsu, Hidefumi
Schlis, Krysta
Davis, Kara
Martin, Paul L.
Nemecek, Eneida
Peters, Christina
Wood, Patricia
Taran, Tetiana
Mueller, Karen Thudium
Zhang, Yiyun
Rives, Susana
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S263 - S264
[45] GLOBAL REGISTRATION TRIAL OF EFFICACY AND SAFETY OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): UPDATE TO THE INTERIM ANALYSIS
Buechner, J.
Grupp, S. A.
Maude, S. L.
Boyer, M.
Bittencourt, H.
Laetsch, T. W.
Bader, P.
Verneris, M. R.
Stefanski, H.
Myers, G. D.
Qayed, M.
Pulsipher, M. A.
De Moerloose, B.
Hiramatsu, H.
Schlis, K.
Davis, K.
Martin, P. L.
Nemecek, E.
Peters, C.
Wood, P.
Taran, T.
Mueller, K. Thudium
Zhang, Y.
Rives, S.
HAEMATOLOGICA, 2017, 102 : 178 - 178
[46] Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Hijiya, Nobuko
Thomson, Blythe
Isakoff, Michael S.
Silverman, Lewis B.
Steinherz, Peter G.
Borowitz, Michael J.
Kadota, Richard
Cooper, Todd
Shen, Violet
Dahl, Gary
Thottassery, Jaideep V.
Jeha, Sima
Maloney, Kelly
Paul, Jo-Anne
Barry, Elly
Carroll, William L.
Gaynon, Paul S.
BLOOD, 2011, 118 (23) : 6043 - 6049
[47] Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
Locatelli, Franco
Zugmaier, Gerhard
Mergen, Noemi
Bader, Peter
Jeha, Sima
Schlegel, Paul-Gerhardt
Bourquin, Jean-Pierre
Handgretinger, Rupert
Brethon, Benoit
Rossig, Claudia
Chen-Santel, Christiane
BLOOD CANCER JOURNAL, 2020, 10 (07)
[48] Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
Franco Locatelli
Gerhard Zugmaier
Noemi Mergen
Peter Bader
Sima Jeha
Paul-Gerhardt Schlegel
Jean-Pierre Bourquin
Rupert Handgretinger
Benoit Brethon
Claudia Rossig
Christiane Chen-Santel
Blood Cancer Journal, 10
[49] Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Lacayo, Norman J.
Pullarkat, Vinod A.
Stock, Wendy
Jabbour, Elias
Bajel, Ashish
Rubnitz, Jeffrey
Leonard, Jessica
Mullighan, Charles G.
Khaw, Seong Lin
Vear, Susan I.
Opferman, Joseph T.
Salem, Ahmed Hamed
Schmidt, Michelle
Tong, Bo
Zhou, Lang
Ross, Jeremy A.
Bensman, Lindsey
Jacobson, Amanda
Norris, Robin
Alexander, Thomas
BLOOD, 2019, 134
[50] Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
Baruchel, Andre
Abrahamsson, Jonas
Bertrand, Yves
Gonzalez, Oscar
Nysom, Karsten
Quinones, Willy
Rizzari, Carmelo
Buechner, Jochen
Cesaro, Simone
Duarte, Joaquin
Fagioli, Franca
Kang, Hyoung Jin
Kattamis, Antonis
Leverger, Guy
Ludwig, Kathleen
Makiya, Monica L.
Micalizzi, Concetta
Nelken, Brigitte
Tondel, Camilla
Yoo, Keon Hee
Ivanina, Inna
Brillac, Claire
Wang, Lynn
Oprea, Corina
Abbadessa, Giovanni
Zwaan, C. Michel
BLOOD, 2021, 138

← 1 2 3 4 5 →